Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last $46.02 USD
Change Today +0.38 / 0.83%
Volume 9.2M
As of 8:04 PM 08/28/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

John M. Capek Ph.D.

Executive Vice President of Ventures,Abbott Laboratories
AgeTotal Calculated CompensationThis person is connected to 0 board members in 0 different organizations across 3 different industries.

As of Fiscal Year 2014


Dr. John M. Capek, Ph.D. has been an Executive Vice President of Ventures at Abbott Laboratories since June 01, 2015. Dr. Capek served as an Executive Vice President of Medical Devices at Abbott Diabetes Care, Inc. from July 2007 to June 01, 2015. Dr. Capek served as an Executive Vice President of Medical Devices at Abbott Laboratories from July 2007 to June 01, 2015, and was responsible for Abbott's Vascular, Diabetes Care, Vision Care and Animal Health businesses. ...

Read Full Background

Corporate Headquarters*

100 Abbott Park Road
Abbott Park, Illinois 60064

United States

Phone: 847-937-6100
Fax: --

Board Members Memberships*

There is no Board Members Memberships data available.


PhD 1987
Rensselaer Polytechnic Institute
Bachelor's Degree 1983
Rensselaer Polytechnic Institute
Master's Degree 1984
Rensselaer Polytechnic Institute
MBA 1987
Rensselaer Polytechnic Institute

Other Affiliations*

Annual Compensation*

Total Annual Compensation$696,807

Stock Options*

Restricted Stock Awards$904,024
All Other Compensation$110,490
Exercisable Options445,034
Unexercisable Options258,644
Total Number of Options703,678

Total Compensation*

Total Annual Cash Compensation$1,461,097
Total Short Term Compensation$696,807
Other Long Term Compensation$1,014,514
Total Calculated Compensation$3,799,395
*Data is at least as current as the most recent Definitive Proxy.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
ABT:US $46.02 USD +0.38


Marc N. Casper Chief Executive Officer, President, Director, Member of Strategy & Finance Committee and Member of Science & Technology Committee
Thermo Fisher Scientific, Inc.
Thomas P. Joyce Jr.Chief Executive Officer, President, Director and Member of Finance Committee
Danaher Corp.
John C. Lechleiter Ph.D.Chairman, Chief Executive Officer and President
Eli Lilly and Company
Erez Vigodman Chief Executive Officer, President, Director and Member of Finance & Invesment Committee
Teva Pharmaceutical Industries Limited
Pascal Soriot Chief Executive Officer, Executive Director and Member of Disclosure Committee
AstraZeneca PLC
3.1M GBP
Compensation as of Fiscal Year 2014.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact ABBOTT LABORATORIES, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at